Inventor · disambiguated record
Jeongbeob Seo
Also filed as: SEO JEONGBEOB
38 granted patents·14 pending applications·624 citations·filing 2004–2023
98Inventor score
Top patents by PatentIndex Score
52 records- 0198US9493476B2Macrocyclic compounds as trk kinase inhibitorsARRAY BIOPHARMA INC·Filed 2014·Granted Nov 15, 2016·46 cites·14 claims
- 0297US9902741B2Macrocyclic compounds as TRK kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Feb 27, 2018·22 cites·15 claims
- 0397US9840519B2Macrocyclic compounds as TRK kinase inhibitorsARRAY BIOPHARMA INC·Filed 2016·Granted Dec 12, 2017·21 cites·5 claims
- 0497US9750744B2Macrocyclic compounds as Trk kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Sep 5, 2017·21 cites·29 claims
- 0597US9718822B2Macrocyclic compounds as Trk kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Aug 1, 2017·22 cites·15 claims
- 0697US8791123B2Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitorsALLEN SHELLEY·Filed 2010·Granted Jul 29, 2014·94 cites·61 claims
- 0796US9796724B2Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Oct 24, 2017·16 cites·30 claims
- 0896US9782415B2Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Oct 10, 2017·19 cites·30 claims
- 0996US7732616B2Dihydropyridine and dihydropyridazine derivatives as inhibitors of MEK and methods of use thereofARRAY BIOPHARMA INC·Filed 2006·Granted Jun 8, 2010·35 cites·1 claims
- 1096US7517994B2Heterocyclic inhibitors of MEK and methods of use thereofARRAY BIOPHARMA INC·Filed 2005·Granted Apr 14, 2009·36 cites·1 claims
- 1195US9682979B2Substituted pyrazolo [1,5-A] pyrimidine compounds as TRK kinase inhibitorsARRAY BIOPHARMA INC·Filed 2014·Granted Jun 20, 2017·27 cites·43 claims
- 1295US8933084B2Macrocyclic compounds as Trk kinase inhibitorsANDREWS STEVEN WADE·Filed 2011·Granted Jan 13, 2015·113 cites·52 claims
- 1393US10647730B2Macrocyclic compounds as TRK kinase inhibitorsARRAY BIOPHARMA INC·Filed 2018·Granted May 12, 2020·4 cites·15 claims
- 1492US7893065B2Heterocyclic inhibitors of MEK and methods of use thereofARRAY BIOPHARMA INC·Filed 2008·Granted Feb 22, 2011·14 cites·20 claims
- 1591US9701681B2Fused ring heteroaryl compounds and their use as Trk inhibitorsCMG PHARMACEUTICAL CO LTD·Filed 2015·Granted Jul 11, 2017·35 cites·19 claims
- 1691US8211921B2Heterocyclic inhibitors of MEK and methods of useBLAKE JAMES F·Filed 2009·Granted Jul 3, 2012·12 cites·5 claims
- 1789US7598383B2Heterocyclic inhibitors of MEK and methods of use thereofARRAY BIOPHARMA INC·Filed 2004·Granted Oct 6, 2009·19 cites·1 claims
- 1888US10251889B2Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Apr 9, 2019·4 cites·18 claims
- 1987US9878997B2Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as TrkA kinase inhibitorsARRAY BIOPHARMA INC·Filed 2016·Granted Jan 30, 2018·4 cites·10 claims
- 2087US9562055B2Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as TrkA kinase inhibitorsALLEN SHELLEY·Filed 2012·Granted Feb 7, 2017·8 cites·61 claims
- 2186US7723330B2Heterobicyclic pyrazole compounds and methods of useARRAY BIOPHARMA INC·Filed 2007·Granted May 25, 2010·11 cites·58 claims
- 2284US8268852B2Heterocyclic inhibitors of MEK and methods of use thereofBLAKE JAMES F·Filed 2009·Granted Sep 18, 2012·4 cites·14 claims
- 2383US8003662B2Heterobicyclic thiophene compounds and methods of useARRAY BIOPHARMA INC·Filed 2007·Granted Aug 23, 2011·9 cites·9 claims
- 2482US10323022B2Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as TrkA kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Jun 18, 2019·2 cites·26 claims
- 2581US8101639B26-oxo-1,6-dihydropyridine compounds as inhibitors of MEK and methods of use thereofMARLOW ALLISON L·Filed 2009·Granted Jan 24, 2012·4 cites·6 claims
- 2681US7576072B2Heterocyclic inhibitors of MEK and methods of use thereofARRAY BIOPHARMA INC·Filed 2004·Granted Aug 18, 2009·9 cites·18 claims
- 2780US8101611B2Substituted pyridazines inhibitors of MEKMARLOW ALLISON L·Filed 2011·Granted Jan 24, 2012·4 cites·10 claims
- 2877US8394795B2Pyrazole [3, 4-B] pyridine Raf inhibitorsAHRENDT KATERI A·Filed 2009·Granted Mar 12, 2013·5 cites·45 claims
- 2975US8211920B26-oxo-1,6-dihydropyridine derivatives as inhibitors of MEK and methods of use thereofMARLOW ALLISON L·Filed 2008·Granted Jul 3, 2012·1 cites·16 claims
- 3073US2020291026A1Macrocyclic compounds as trk kinase inhibitorsARRAY BIOPHARMA INC·Filed 2020·Application pending·0 cites
- 3170US10758542B2Substituted pyrazolo[l,5-a]pyrimidine compounds as Trk kinase inhibitorsARRAY BIOPHARMA INC·Filed 2019·Granted Sep 1, 2020·0 cites·11 claims
- 3267US8664230B2Pyridopyrimidine derivatives and use thereofLEE GILNAM·Filed 2012·Granted Mar 4, 2014·3 cites·3 claims
- 3363US2019359597A1Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as trka kinase inhibitorsARRAY BIOPHARMA INC·Filed 2019·Application pending·0 cites
- 3460US2012263679A1Combinations Comprising Heterocyclic Inhibitors of MEK and Methods of Use ThereofMARLOW ALLISON L·Filed 2012·Application pending·0 cites
- 3560US2013018075A1Heterocyclic inhibitors of mek and methods of use thereofMARLOW ALLISON L·Filed 2012·Application pending·0 cites
- 3658US2011178136A1Heterocyclic inhibitors of mek and methods of use thereofARRAY BIOPHARMA INC·Filed 2011·Application pending·0 cites
- 3756US2011288092A1Heterocyclic Inhibitors of MEK and Methods of Use ThereofMARLOW ALLISON L·Filed 2010·Application pending·0 cites
- 3849US12240830B2Fused ring heteroaryl compounds and use thereofBISICHEM CO LTD·Filed 2022·Granted Mar 4, 2025·0 cites·3 claims
- 3948US8299076B2Crystalline forms of 2-(2-flouro-4-iodophenylamino)-N-(2-hydroxyethoxy)-1,5-dimethyl-6-oxo-1,6-dihydropyridine-3-carboxamideMARLOW ALLISON L·Filed 2006·Granted Oct 30, 2012·0 cites·24 claims
- 4048US2024083892A1Fused heterocyclic rings as ripk1 inhibitorsBISICHEM CO LTD·Filed 2022·Application pending·0 cites
- 4147US2023219931A1Fused heteroaryl hydroxamates as sting agonistsBISICHEM CO LTD·Filed 2023·Application pending·0 cites
- 4247US2011130406A1Pyrazolo-pyridines as tyrosine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2008·Application pending·0 cites
- 4346US12365695B2Fused ring heteroaryl compounds as RIPK1 inhibitorsBISICHEM CO LTD·Filed 2020·Granted Jul 22, 2025·0 cites·14 claims
- 4445US2014113915A1Novel pyridopyrimidine derivatives and use thereofASAN FOUNDATION·Filed 2013·Application pending·0 cites
- 4544US2011053931A1Quinoline compounds and methods of useGAUDINO JOHN·Filed 2007·Application pending·0 cites
- 4641US2021139435A1Prostaglandin analogs and uses thereofLIFEX BIOLABS INC·Filed 2020·Application pending·0 cites
- 4741US2010256356A1Heterobicyclic pyrazole compounds and methods of useARRAY BIOPHARMA INC·Filed 2010·Application pending·0 cites
- 4839US11932639B2Fused ring heteroaryl compounds as ALK4/5 inhibitorsBISICHEM CO LTD·Filed 2020·Granted Mar 19, 2024·0 cites·5 claims
- 4938US9422298B2Pyridopyrimidine derivatives and use thereofCMG PHARMACEUTICAL CO LTD·Filed 2015·Granted Aug 23, 2016·0 cites·2 claims
- 5034US10494343B2Organic compound, near-infrared fluorescent constant medium containing same, and method for nano-granulating constant mediumCOLLEGE OF MEDICINE POCHON CHA UNIV INDUSTRY—ACADEMIC COOPERATION FOUND·Filed 2016·Granted Dec 3, 2019·0 cites·10 claims
Showing the top 50 of 52 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Jeongbeob Seo files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →